Blinkbiomedical
Marseille, FR · 1 known investors
BliNK Biomedical develops a B cell technology, based on the ISAAC and VIVA|Screen platforms, to identify and isolate specific antibody-producing cells for difficult targets from human and other species such as mouse, rabbit, and dog. The company applies this platform to discover rare antibody-secreting cells and identify therapeutic antibodies.
BiotechDeep Tech
Investors · 1
Frequently asked questions
- What does Blinkbiomedical do?
- BliNK Biomedical develops a B cell technology, based on the ISAAC and VIVA|Screen platforms, to identify and isolate specific antibody-producing cells for difficult targets from human and other species such as mouse, rabbit, and dog. The company applies this platform to discover rare antibody-secreting cells and identify therapeutic antibodies.
- Who are Blinkbiomedical's investors?
- Blinkbiomedical's investors include Kurma Partners.
- Where is Blinkbiomedical headquartered?
- Blinkbiomedical is headquartered in Marseille, FR.